SEBI Reg. Investment Advisor

Download App
Help Center Pricing
Money Works 4 Me Logo MoneyWorks4Me
Talk to Advisor
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

Jubilant Ingrevia Ltd (JUBLINGREA)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 543271 NSE: JUBLINGREA Chemicals | Small Cap | Jubilant Ingrevia Share Price

₹626 3.90 (0.63%)

As on 05-Jun'26 16:59

Jubilant Ingrevia Ltd (JUBLINGREA)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 543271 NSE: JUBLINGREA Chemicals | Small Cap | Jubilant Ingrevia Share Price

₹626 3.90 (0.63%)

As on 05-Jun'26 16:59

Key Metrics
Valuation Multiples
Market Cap
₹9,909 Cr.
Current Price
₹626
52-Week Low / High
₹535 / 852
TTM EPS
₹16.8
TTM Sales
₹4,097 Cr.
Book Value per Share
₹165.8
P/E Ratio
36.98
Lower than its 5-year historical median
Industry PE
50.2
Price to Book (P/B)
3.75
Lower than its 5-year historical median
Price to Sales (P/S)
2.42
Higher than its 5-year historical median
EV/EBITDA
18.26
Lower than its 5-year historical median
Dividend Yield
0.77%
Profitability Efficiency
Return on Equity (ROE)
11.30%
Outperforms industry median
Return on Capital Employed (ROCE)
12.96%
In line with industry median
Return on Assets (ROA)
5.95%
Operating Profit Margin
12.2%
Net Profit Margin
6.68%
Gross Profit Margin
12.5%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
-1.15%
Operating Profit Growth (1 Year)
Improving versus 3-year growth rate
17.82%
Net Profit Growth (1 Year)
Improving versus 3-year growth rate
62.16%
Asset Quality
Promoter Holding
45.22%
Pledged shares (%) of Promoter's holding (%)
7.64%
Reserves
₹2,624 Cr.
Equity
₹15.9 Cr.
Face Value
₹1
All Time Low / High
₹243.60 / 884.95

Jubilant Ingrevia stock performance

Key Ratios
mw4me loader

Check Before You Invest

Check Before You Invest

Quality

Somewhat Good
Check detailed performance

Valuation

Fair

Check Valuation charts

Price Trend

Weak
Check Price chart
Q.1 Is Jubilant Ingrevia Ltd a good quality company?
Jubilant Ingrevia Ltd is a average quality company, based on a somewhat consistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

View More

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

View More
How does Jubilant Ingrevia Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Jubilant Ingrevia Ltd vs industry peers?
Jubilant Ingrevia Ltd revenue CAGR is 0.00%, compared to the industry median CAGR of 7.53%, indicating slower growth and losing its market share.
Q.1 Promoter shareholding and pledge status of Jubilant Ingrevia Ltd?
Promoters hold 45.22% of the Jubilant Ingrevia Ltd, with 7.64% of their stake pledged, indicating low pledge risk.
Q.1 Stock return of Jubilant Ingrevia Ltd over the last decade?
Over the last 5 year(s), the stock has delivered a CAGR of 10.87% based on the current price.
View More

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Jubilant Ingrevia Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation ⓘ

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % ⓘ0%0%0%0%0%5.6%30.6%15.7%10.5%13%-
Value Creation
Index ⓘ		NANANANANA-0.61.30.2-0.20.0-

Growth Parameters ⓘ
Sales ⓘ000006694,8604,5603,9873,9414,097
Sales YoY Gr.-NANANANANA626.6%-6.2%-12.6%-1.2%-
Adj EPS ⓘ0000-3.33.129.116.710.616.816.8
YoY Gr.-NANANANANA833.7%-42.6%-36.7%58.6%-
BVPS (₹) ⓘ0000-2.398.9124.4135.3140.5152.2165.8
Adj Net
Profit ⓘ		0000-0.249.7464266169267268
Cash Flow from Ops. ⓘ00000104587446394441-
Debt/CF from Ops. ⓘ000007.10.71.42.11.8-

CAGR ⓘ

9 Years 5 Years 3 Years 1 Years
Sales ⓘNANA-6.8%-1.2%
Adj EPS ⓘNANA-16.8%58.6%
BVPSⓘNANA6.9%8.3%
Share Price - 1.8% 15.2% -11.5%

Key Financial Parameters ⓘ

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity % ⓘ		0000143.16.326.112.97.711.410.6
Op. Profit
Mgn % ⓘ		0000014.917.111.310.312.211.5
Net Profit
Mgn % ⓘ		000007.49.65.84.26.86.5
Debt to
Equity ⓘ		000000.50.20.30.40.30.1
Working Cap
Days ⓘ		0000033410612814414775
Cash Conv.
Cycle ⓘ		00000152238434612

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales06694,8604,5603,9873,941
Operating Expenses ⓘ + 05724,0474,0653,5843,466
Manufacturing Costs01137311,025827771
Material Costs03882,8682,5372,1502,088
Employee Cost 043292306345376
Other Costs ⓘ 028156198263231
Operating Profit ⓘ -097813495403475
Operating Profit Margin (%) -14.5%16.7%10.8%10.1%12.0%
Other Income ⓘ + 0229313681
Exceptional Items ⓘ 0-130000
Interest ⓘ 0946386665
Depreciation ⓘ 021120120133147
Profit Before Tax ⓘ -056675368239343
Tax ⓘ 0172231147780
Profit After Tax -039452253162263
PAT Margin (%) -5.8%9.3%5.6%4.1%6.7%
Adjusted EPS (₹)-3.32.428.415.910.216.5
Dividend Payout Ratio (%)0%14.50%17.60%31.40%49%30.20%

Valuation of Jubilant Ingrevia - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund + -01,5761,9822,1552,2382,424
Share Capital ⓘ 01616161616
Reserves ⓘ -01,5601,9662,1392,2222,408
Debt +0647425601805704
Long Term Debt0647296337396350
Short Term Debt00129263409354
Minority Interest000000
Trade Payables0690795810757796
Others Liabilities ⓘ 0327451493541597
Total Liabilities ⓘ 03,2403,6524,0584,3404,521

Fixed Assets

Net Fixed Assets ⓘ +01,7271,7281,7752,2922,335
Gross Block02,2352,3502,5073,1423,304
Accumulated Depreciation0508622731850968
CWIP ⓘ 065167477181197
Investments ⓘ 0135139172297310
Inventories0521763880775804
Trade Receivables0480585497563573
Cash Equivalents 08624372051
Others Assets ⓘ 0227247221213250
Total Assets ⓘ 03,2403,6524,0584,3404,521

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity ⓘ + 0104587446394441
PBT ⓘ -056675368239343
Adjustment ⓘ 047179160211176
Changes in Working Capital ⓘ 012-156-10-23-5
Tax Paid ⓘ 0-11-111-72-33-74
Cash Flow From Investing Activity ⓘ + 0-29-221-475-464-211
Capex 0-27-222-443-339-203
Net Investments 00000-8
Others ⓘ 0-21-32-125-0
Cash Flow From Financing Activity ⓘ + 0-70-4103364-208
Net Proceeds from Shares ⓘ 000000
Net Proceeds from Borrowing ⓘ 0-62-44358192-65
Interest Paid ⓘ 0-8-48-60-82-81
Dividend Paid ⓘ 00-45-79-79-80
Others ⓘ 0-01261143317
Net Cash Flow ⓘ 05-443-622

Financial Ratio

PARTICULARSMar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)N/A4.925.4312.257.411.3
ROCE (%)N/A5.6230.5815.7110.4612.96
Asset Turnover Ratio00.411.411.180.950.89
PAT to CFO Conversion(x)N/A2.671.31.762.431.68
Working Capital Days
Receivable Days0261.304043.2048.5052.60
Inventory Days0283.2048.1065.7075.8073.20
Payable Days0324.6094.50115.40133135.80

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *3.453.452.712.712.712.712.227.087.087.64
* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Jubilant Ingrevia Ltd FAQs

The current trading price of Jubilant Ingrevia on 05-Jun-2026 16:59 is ₹626.0.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Jun-2026 the market cap of Jubilant Ingrevia stood at ₹9,908.9 Cr

The latest P/E ratio of Jubilant Ingrevia as of 04-Jun-2026 is 36.98.

The latest P/B ratio of Jubilant Ingrevia as of 04-Jun-2026 is 3.75.

The 52-week high of Jubilant Ingrevia is ₹851.9 and the 52-week low is ₹535.3.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Jubilant Ingrevia is ₹4,097 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Jubilant Ingrevia Ltd is a average quality company.

The key valuation ratios of Jubilant Ingrevia Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Jubilant Ingrevia Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Jubilant Ingrevia Ltd

Jubilant Ingrevia is a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers with its customised products and solutions that are innovative, cost-effective and conforming to excellent quality standards. Jubilant Ingrevia is the demerged pharma and life sciences business of Jubilant Lifesciences and listed on the exchanges in FY21.

Business area of the company

The company offers a broad portfolio of high-quality ingredients that find application in a wide range of industries. The company’s portfolio also extends to custom research and manufacturing for pharmaceutical and agrochemical customers on an exclusive basis.

Product and services

Speciality Chemicals
  • Speciality Ingredients
  • Fine Chemicals
  • Crop Protection Chemicals
  • CDMO
Nutrition & Health Solutions
  • Nutrition & Health Ingredients
  • Animal Nutrition & Health Solutions
  • Human Nutrition & Health Solutions
Life Science Chemicals
  • Life Science Ingredients
  • Speciality Ethanol
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×